Cingulate

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cingulate and other ETFs, options, and stocks.

About CING

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). 

CEO
Shane J. Schaffer
CEOShane J. Schaffer
Employees
13
Employees13
Headquarters
Kansas City, Kansas
HeadquartersKansas City, Kansas
Founded
2012
Founded2012
Employees
13
Employees13

CING Key Statistics

Market cap
16.87M
Market cap16.87M
Price-Earnings ratio
-0.26
Price-Earnings ratio-0.26
Dividend yield
Dividend yield
Average volume
98.25K
Average volume98.25K
High today
$4.44
High today$4.44
Low today
$4.21
Low today$4.21
Open price
$4.29
Open price$4.29
Volume
104.56K
Volume104.56K
52 Week high
$20.83
52 Week high$20.83
52 Week low
$1.80
52 Week low$1.80
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.